指南与共识慢性肾脏病遗传性与小管间质肾病

欧洲共识声明:CKD G4-G5D期骨质疏松症的诊断与管理

European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D.
指南 / 共识 · Nephrol Dial Transplant · 2021-01-01

该共识声明针对CKD G4-G5D期患者骨质疏松症的诊断与管理,指出骨折负担控制面临双重挑战:骨脆性病理生理复杂,且现有骨质疏松药物未在该人群充分研究。声明旨在更新评估诊断方法并讨论治疗干预,以制定脆性骨折预防管理策略,替代当前诊疗差异与治疗虚无主义。

要点

  • CKD G4-G5D期骨脆性由年龄相关、药物诱导及CKD相关骨异常混合构成。
  • 现有骨质疏松药物未为CKD G4-G5D期患者开发或充分研究。
  • 共识旨在统一诊疗路径,替代当前治疗虚无主义与差异。

核心结论

  • 需建立CKD G4-G5D期骨质疏松症的统一管理策略以预防脆性骨折并替代治疗虚无主义。

研究设计与样本

  • 欧洲共识声明,基于综述与更新CKD G4-G5D期骨质疏松评估诊断及治疗干预。

主要发现

  • CKD G4-G5D期骨脆性病理生理复杂,混合年龄相关、药物诱导及CKD相关骨异常。
  • 现有骨质疏松药物未为该人群开发或充分研究,部分因诊断困难及并发症担忧。
  • 诊断与治疗最佳方案的疑虑加剧日常临床实践中的惰性。

临床怎么用

  • 临床应 cohesive 管理CKD G4-G5D期骨质疏松,避免治疗虚无主义与诊疗差异。

局限性

  • 现有骨质疏松药物在CKD G4-G5D期患者中缺乏充分研究,诊断存在困难。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Controlling the excessive fracture burden in patients with chronic kidney disease (CKD) Stages G4-G5D remains an impressive challenge. The reasons are 2-fold. First, the pathophysiology of bone fragility in patients with CKD G4-G5D is complex and multifaceted, comprising a mixture of age-related (primary male/postmenopausal), drug-induced and CKD-related bone abnormalities. Second, our current armamentarium of osteoporosis medications has not been developed for, or adequately studied in patients with CKD G4-G5D, partly related to difficulties in diagnosing osteoporosis in this specific setting and fear of complications. Doubts about the optimal diagnostic and therapeutic approach fuel inertia in daily clinical practice. The scope of the present consensus paper is to review and update the assessment and diagnosis of osteoporosis in patients with CKD G4-G5D and to discuss the therapeutic interventions available and the manner in which these can be used to develop management strategies for the prevention of fragility fracture. As such, it aims to stimulate a cohesive approach to the management of osteoporosis in patients with CKD G4-G5D to replace current variations in care and treatment nihilism.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Evenepoel P, Cunningham J, Ferrari S, et al. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D. Nephrol Dial Transplant. 2021. PMID: 33098421. doi:10.1093/ndt/gfaa192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。